New study tests blood markers for early diabetic kidney disease detection
NCT ID NCT07173686
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study will check if certain blood markers—like MCP-1, NLR, and hsCRP—can help detect kidney disease early in people with type 2 diabetes. Researchers will measure these markers in 80 adults and compare them to standard kidney tests. The goal is to find a simpler way to identify kidney damage before it becomes severe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward a simple blood test to catch diabetic kidney disease earlier, allowing for timely treatment.
- What could go wrong
- This is a small, early-stage observational study, not a treatment trial. The markers may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a milk protein shield kidneys from diabetes damage?
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
- Ancient herbal formula put to the test against diabetic kidney disease
- Baking soda may cut kidney risk in type 1 diabetes
- Could a herbal tablet protect kidneys in diabetes?
- Kidney hope: two-pill combo may slow damage in diabetic patients